Van Heron Labs leverages advanced technologies in genetics, bioinformatics, and artificial intelligence to optimize cell culture processes and enhance the health of both humans and the planet. Their approach focuses on precision feeding, which involves analyzing the genetic data of cells to determine their specific nutritional needs. This method allows for the design of tailored media formulations that streamline cellular metabolism, reduce unnecessary metabolic steps, and ultimately improve cell density and productivity. By transitioning to chemically defined media, Van Heron Labs addresses the limitations of traditional cell culture methods, which often rely on trial and error and contain undefined components that can negatively impact cell performance.

The company's innovative platform is applicable across various industries, including cellular agriculture, biologics, cell therapy, gene therapy, and precision fermentation. By utilizing multi-omics data and proprietary bioinformatics tools, Van Heron Labs can create optimized nutrient formulations that enhance the robustness of bio-processes. Their technology has demonstrated significant improvements in cell growth and productivity, achieving up to 900% increases in mammalian cell density and 360% increases in bacterial protein production. This precision nutrition approach not only reduces production costs but also accelerates the development timelines for bio-based products, making it a valuable solution for the challenges faced in biomanufacturing and therapeutic production.

United States

Van Heron Labs is a company that develops technologies to enhance the health of humans and the planet by utilizing the power of genetics, bioinformatics, and AI to unify nutrient substrates. The company's cell-based applications include cancer therapeutics and food and materials production.

Van Heron Labs

Company Details